Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10

BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder in reproductive-age women. Excessive inflammation and elevated androgen production from ovarian theca cells are key features of PCOS. Human bone marrow mesenchymal stem cells (BM-hMSC) and their secreted...

Descripción completa

Detalles Bibliográficos
Autores principales: Chugh, Rishi Man, Park, Hang-soo, El Andaloussi, Abdeljabar, Elsharoud, Amro, Esfandyari, Sahar, Ulin, Mara, Bakir, Lale, Aboalsoud, Alshimaa, Ali, Mohamed, Ashour, Dalia, Igboeli, Prosper, Ismail, Nahed, McAllister, Jan, Al-Hendy, Ayman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261924/
https://www.ncbi.nlm.nih.gov/pubmed/34233746
http://dx.doi.org/10.1186/s13287-021-02472-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261924/
https://www.ncbi.nlm.nih.gov/pubmed/34233746
http://dx.doi.org/10.1186/s13287-021-02472-w

Ejemplares similares